MBD4 is critical for genome stability and preventing mutations, and loss of function of MBD4 has recently been associated with a higher risk of MBD4-associated neoplasia syndrome, a multiorgan tumor predisposition syndrome (Palles et al. 2022). Here, MBD4 is linked to BAP1-related tumor predisposition syndrome.